Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1308
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01664091 | Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT | ||
| NCT01253369 | Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer | ||
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT02441140 | Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis | ||
| NCT05366413 | Early Interventional Treatment for Cancer Pain | ||
| NCT05499520 | Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women | ||
| NCT04339062 | Cemiplimab in AlloSCT/SOT Recipients With CSCC | ||
| NCT02977780 | INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | ||
| NCT00459069 | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | ||
| NCT03436654 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | ||
| NCT01476462 | Second Malignant Neoplasms After Childhood ALL Therapy | ||
| NCT00483262 | Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | ||
| NCT06153797 | A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | ||
| NCT04007588 | A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma | ||
| NCT02648997 | An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma | ||
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | ||
| NCT00895661 | High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas | ||
| NCT00973440 | Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies | ||
| NCT04323774 | Intervention For AYAS With Cancer Risk Syndromes | ||
| NCT01805089 | Melatonin Versus Placebo in Breast Cancer | ||
| NCT07198724 | ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer | ||
| NCT04033497 | Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases | ||
| NCT02756390 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | ||
| NCT06333262 | Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia | ||
| NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | ||
| NCT01331291 | Bosutinib in Adult Patients With Recurrent Glioblastoma | ||
| NCT04917796 | The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) | ||
| NCT00529035 | Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease | ||
| NCT04781374 | Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT06923397 | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | ||
| NCT03993210 | The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids | ||
| NCT00006123 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer | ||
| NCT04936243 | TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | ||
| NCT00136474 | Amifostine for Head and Neck Irradiation in Lymphoma | ||
| NCT01191060 | Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years | ||
| NCT07027748 | Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma | ||
| NCT01058408 | RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer | ||
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | ||
| NCT03692325 | Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia | ||
| NCT07465276 | Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC | ||
| NCT06100874 | A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) | ||
| NCT01734915 | Detecting EGFR T790M Mutations From Circulating Tumor Cells | ||
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | ||
| NCT04895436 | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT01465334 | Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL | ||
| NCT02201212 | Everolimus for Cancer With TSC1 or TSC2 Mutation | ||
| NCT01286675 | Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT | ||
| NCT03410875 | A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia |
